This is really disappointing. As there are millions in great need of a positive therapy. And the reason(s) this isn’t going ahead seem to be a strange mixture of definitions of what’s being approved (“a drug” or “a therapy” …utilizing a drug), and a lack of expertise on the FDA board about the clinical effects of psilocybin based therapies. BBC source
13 Likes
